{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:01:02Z","timestamp":1791475262301,"version":"4.3.4"},"reference-count":64,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1516,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Environmental factors, especially the diet, play a prominent role in the epidemic of prostate cancer (PCA), in the United States. Many candidate dietary components have been proposed to influence human prostatic carcinogenesis, including fat, calories, fruits and vegetables, anti\u2010oxidants, and various micronutrients, but the specific roles dietary agents play in promoting or preventing PCA remain controversial. We have collected evidence to suggest that <jats:italic>GSTP1<\/jats:italic>, the gene encoding the \u03c0\u2010class glutathione <jats:italic>S<\/jats:italic>\u2010transferase (GST), may serve a \u201ccaretaker\u201d function for prostatic cells. Although GSTP1 can be detected in normal prostatic epithelium, in almost all PCA cases, PCA cells fail to express GSTP1 polypeptides, and lack of GSTP1 expression most often appears to be the result of somatic \u201cCpG island\u201d DNA methylation changes. Loss of <jats:italic>GSTP1<\/jats:italic> function also appears to be characteristic of prostatic epithelial neoplasia (PIN) lesions, thought to represent PCA precursors. We have recently learned that a new candidate early PCA precursor lesion, proliferative inflammatory atrophy (PIA), characterized by proliferating prostatic cells juxtaposed to inflammatory cells, contains epithelial cells that express high levels of GSTP1. These findings have formed the basis for a new model of prostatic carcinogenesis, in which prostatic cells in PIA lesions, subjected to a barrage of inflammatory oxidants, induce GSTP1 expression as a defense against oxidative genome damage. When cells with defective <jats:italic>GSTP1<\/jats:italic> genes appear amongst the PIA cells, such cells become vulnerable to oxidants and electrophiles that inflict genome damage that tends to promote neoplastic transformation to PIN and PCA cells. Subsequently, PIN and PCA cells with defective <jats:italic>GSTP1<\/jats:italic> genes remain vulnerable to similar stresses tending to promote malignant progression. This new model for prostatic carcinogenesis has implications for the design of new prostate cancer prevention strategies. Rational prevention approaches might include: (i) <jats:italic>restoration<\/jats:italic> of <jats:italic>GSTP1<\/jats:italic> expression via treatment with inhibitors of CpG methylation, (ii) <jats:italic>compensation<\/jats:italic> for inadequate GSTP1 activity via treatment with inducers of general GST activity, and (iii) <jats:italic>abrogation<\/jats:italic> of genome\u2010damaging stresses via avoidance of exogenous carcinogens and\/or reduction of endogenous carcinogenic (particularly oxidant) stresses.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb02734.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T23:48:17Z","timestamp":1279669697000},"page":"135-144","source":"Crossref","is-referenced-by-count":88,"title":["Preneoplastic Prostate Lesions"],"prefix":"10.1111","volume":"952","author":[{"given":"WILLIAM G.","family":"NELSON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANGELO M.","family":"DE MARZO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"THEODORE L.","family":"DEWEESE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIAOHUI","family":"LIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAMES D.","family":"BROOKS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MATTHEW J.","family":"PUTZI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHAD P.","family":"NELSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN D.","family":"GROOPMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"THOMAS W.","family":"KENSLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990160105"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199505000-00014"},{"key":"e_1_2_8_4_2","doi-asserted-by":"crossref","unstructured":"Landis S.H. T. Murray S. Bolden & P.A. Wingo. 1999. Cancer statistics 1999 [see comments]. CA Cancer J. Clin.49:8\u201031 31.","DOI":"10.3322\/canjclin.49.1.8"},{"key":"e_1_2_8_5_2","doi-asserted-by":"crossref","unstructured":"Parkin D.M. P. Pisani & J. Ferlay. 1999. Global cancer statistics. CA Cancer J. Clin.49:33\u201064 31.","DOI":"10.3322\/canjclin.49.1.33"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)40078-4"},{"key":"e_1_2_8_7_2","first-page":"193","article-title":"The epidemiology of prostate cancer part II: the risk factors","volume":"16","author":"Brawley O.W.","year":"1998","journal-title":"Semin. Urol. Oncol."},{"key":"e_1_2_8_8_2","first-page":"43","article-title":"Studies of Japanese migrants","volume":"40","author":"Haenszel W.","year":"1968","journal-title":"I. Mortality from cancer and other diseases among Japanese in the United States. J. Natl. Cancer Inst."},{"key":"e_1_2_8_9_2","first-page":"291","article-title":"Cancer mortality among the Polish\u2010born in the United States","volume":"35","author":"Staszewski J.","year":"1965","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55777-8"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1998.00630.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540240035027"},{"key":"e_1_2_8_13_2","first-page":"1225","article-title":"Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis","volume":"59","author":"Gann P.H.","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.4.317"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.16.1219"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.23.1767"},{"key":"e_1_2_8_17_2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/jnci\/90.6.440","article-title":"Prostate cancer and supplementation with alpha\u2010tocopherol and beta\u2010carotene: incidence and mortality in a controlled trial [see comments]","volume":"90","author":"Heinonen O.P.","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.0986"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.12.5258"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910200506"},{"key":"e_1_2_8_21_2","first-page":"439","article-title":"High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20\u201069: an autopsy study of 249 cases","volume":"8","author":"Sakr W.A.","year":"1994","journal-title":"In Vivo"},{"key":"e_1_2_8_22_2","first-page":"531","article-title":"CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia","volume":"7","author":"Brooks J.D.","year":"1998","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_2_8_23_2","first-page":"443","article-title":"CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker","volume":"6","author":"Lee W.H.","year":"1997","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.24.11733"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63028-3"},{"key":"e_1_2_8_26_2","doi-asserted-by":"crossref","unstructured":"Kinzler K.W. & B. Vogelstein. 1997. Cancer\u2010susceptibility genes. Gatekeepers and caretakers [news; comment] [see comments]. Nature386:761 763.","DOI":"10.1038\/386761a0"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.1.259"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.14.1227"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.1.40"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/14.11.2313"},{"key":"e_1_2_8_31_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0278-6915(95)00025-W","article-title":"Heterocyclic amine content in fast\u2010food meat products","volume":"33","author":"Knize M.G.","year":"1995","journal-title":"Food Chem. Toxicol."},{"key":"e_1_2_8_32_2","first-page":"3367","article-title":"Metabolism of 2\u2010acetylaminofluorene and benzo(a)pyrene and activation of food\u2010derived heterocyclic amine mutagens by human cytochromes P\u2010450","volume":"50","author":"McManus M.E.","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1991.tb01855.x"},{"key":"e_1_2_8_34_2","first-page":"1070","article-title":"Some perspectives on the nutritional aspects of breast cancer research","volume":"74","author":"Snyderwine E.G.","year":"1994","journal-title":"Food\u2010derived heterocyclic amines as etiologic agents in human mammary cancer. Cancer"},{"key":"e_1_2_8_35_2","first-page":"1665","article-title":"2\u2010Amino\u20101\u2010methyl\u20106\u2010phenylimidazo[4,5\u2010\u03b2]pyridine is a potent mutagen in the mouse small intestine","volume":"54","author":"Brooks R.A.","year":"1994","journal-title":"Cancer Res."},{"key":"e_1_2_8_36_2","doi-asserted-by":"crossref","unstructured":"Carmichael P.L. E.M. Stone P.L. Grover et al1996. Metabolic activation and DNA binding of food mutagens and other environmental carcinogens in human mammary epithelial cells. Carcinogenesis17:1769\u20101772.","DOI":"10.1093\/carcin\/17.8.1769"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/15.4.641"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/16.4.713"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1992.tb02716.x"},{"key":"e_1_2_8_40_2","first-page":"266","article-title":"Prostate mutations in rats induced by the suspected human carcinogen 2\u2010amino\u20101\u2010methyl\u20106\u2010phenylimidazo[4,5\u2010\u03b2]pyridine","volume":"60","author":"Stuart G.R.","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_8_41_2","first-page":"195","article-title":"The prostate: a target for carcinogenicity of 2\u2010amino\u20101\u2010methyl\u20106\u2010phenylimidazo[4,5\u2010\u03b2]pyridine (PhIP) derived from cooked foods","volume":"57","author":"Shirai T.","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_8_42_2","first-page":"103","article-title":"Protection against 2\u2010hydroxyamino\u20101\u2010methyl\u20106\u2010phenylimidazo [4,5\u2010\u03b2]pyridine (N\u2010OH\u2010PhIP) cytotoxicity and DNA adduct formation in human prostate by glutathione S\u2010transferase P1","volume":"61","author":"Nelson C.P.","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1101\/SQB.1994.059.01.075"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65517-4"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700680234"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198808000-00003"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990200109"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1968.tb00475.x"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.49.9.741"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00776-7"},{"key":"e_1_2_8_51_2","first-page":"663","article-title":"GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas","volume":"16","author":"Tchou J.C.","year":"2000","journal-title":"Int. J. Oncol."},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/30764"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/561"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/5047"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/77023"},{"key":"e_1_2_8_56_2","first-page":"4515","article-title":"Inactivation of glutathione S\u2010transferase P1 gene by promoter hypermethylation in human neoplasia","volume":"58","author":"Esteller M.","year":"1998","journal-title":"Cancer Res."},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202415"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M906538199"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60265-1"},{"key":"e_1_2_8_60_2","first-page":"2448s","article-title":"Inhibition of neoplasia by minor dietary constituents","volume":"43","author":"Wattenberg L.W.","year":"1983","journal-title":"Cancer Res."},{"key":"e_1_2_8_61_2","first-page":"127","article-title":"Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers","volume":"7","author":"Kensler T.W.","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_8_62_2","first-page":"257","article-title":"Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes","volume":"6","author":"Jacobson L.P.","year":"1997","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.8.3147"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.6.2399"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.19.10367"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb02734.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb02734.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb02734.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T12:14:36Z","timestamp":1696767276000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb02734.x"}},"subtitle":["An Opportunity for Prostate Cancer Prevention"],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb02734.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb02734.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}